Skip to main content
idi
Toggle navigation
0
You have 0 notifications
Site Visitor
Site Visitor
New To Inknowvation.com?
Register now to get an access to proprietary SBIR-STTR databases!
Registration is fast and free - start your access to business-actionable information today!
Login
Site Register
SBIR-STTR Award
You are here:
Home
Search Databases
Search SBIR-STTR Awards
SBIR-STTR Award
7
Clonogenic High Throughput Asssay for Screening Radiation Modulators
Award last edited on: 7/17/2018
Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$297,604
Award Phase
1
Solicitation Topic Code
NCI
Principal Investigator
Barbara Frederick
Company Information
Suvica Inc
PO Box 3131
Boulder, CO 80307
(303) 921-6680
info@suvica.com
www.suvica.com
Location:
Single
Congr. District:
02
County:
Boulder
Phase I
Contract Number:
----------
Start Date:
----
Completed:
----
Phase I year
2017
Phase I Amount
$297,604
Clonogneic assays measure the ability of single cells to proliferate and form a colony This process approximates closely the regrowth and recurance of tumors after treatment with radiation or chemotherapy providing a ready assay to screen for drugs that block this process Yet clonogenic assays are laborintensive and too cumbersome for high throughout screening HTS of compound libraries Here we propose to develop a HTS system based on a clonogenic endpoint A close examination of the literature and our own work shows that all necessary components for an HTS with a clonogenic endpoints already exist through efforts in the industry and academia We will combine these and validate their utility by comparing with conventional clonogenic assays to produce an HTS system with defined and validated standared opeating procedures This system will be transferrable to other laboratories Potential commercial applications include screening compound libraries for hits with dose modification for radiation or chemotherapeutics The HTS system we propose to develop will allow us to identify new compounds with the potential to inhibit regrowth of tumors after treatment The HTS system will also allow us to rapidly test the efficacy of combining existing drugs or drugs with radiation thus identifying rational treatment combinations
Phase II
Contract Number:
----------
Start Date:
----
Completed:
----
Phase II year
----
Phase II Amount
----
×
Login to your account
Mail sent successfully.
Enter any username and password.
Username
Password
Remember me
Login
Forgot your username?
Click here for assistance
Forgot your password?
Request new password
Don't have an account?
Sign up
Forgot username?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.
Forgot password?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.